Matthew Concienne, PA
Medical · Richland, WANPI 1629521349
Payments from drug & device makers
Across 30 payments — averaging $33.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- C. R. Bard, Inc. & Subsidiaries$303
- 180 Medical, Inc.$138
- Procept Biorobotics Corporation$137
- Axonics, Inc.$136
- Endo Pharmaceuticals Inc.$64
- Endo USA, Inc.$54
- plus $183 from 5 others
What the payments were for
- Food & beverage$1,014100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| C. R. Bard, Inc. & Subsidiaries | 10 | $303 |
| 180 Medical, Inc. | 5 | $138 |
| Procept Biorobotics Corporation | 1 | $137 |
| Axonics, Inc. | 2 | $136 |
| Endo Pharmaceuticals Inc. | 3 | $64 |
| Endo USA, Inc. | 2 | $54 |
| Boston Scientific | 2 | $47 |
| Coloplast | 2 | $44 |
| Urogen Pharma, Inc. | 1 | $43 |
| Novo Nordisk | 1 | $30 |
| Photocure Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$137
- Axonics$120
How this compares
$1,014 in reported general payments places this provider in the 75th percentile of 457 medical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 51 | $47,406 |
| GemtesaVibegron | 44 | $35,562 |
| Tamsulosin Hcl | 993 | $16,963 |
| Finasteride | 992 | $15,593 |
| Mirabegron ErMirabegron | 11 | $9,073 |
| Estradiol | 71 | $5,271 |
| Tolterodine Tartrate ErTolterodine Tartrate | 26 | $2,945 |
| Silodosin | 23 | $2,784 |
| Trospium Chloride | 25 | $2,522 |
| Dutasteride | 46 | $2,368 |
| Solifenacin Succinate | 33 | $1,238 |
| Testosterone | 12 | $947 |
| Doxazosin Mesylate | 36 | $787 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 31 | $664 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $324 |
Paid to pharmacies, not to this prescriber.
Other medical in Richland
- Patricia HernandezRichland$9K
- Chaunce RuffRichland$8K
- Gary StrongRichland$8K
- Kishore VaradaRichland$6K
- Tauni UrdahlRichland$3K
- Diana McFarlaneSeattle$95K
- Karissa SecoraTacoma$53K
- Tori FranklinLakewood$23K
- Christian GarridoSpokane$22K
- Salvador LopezYakima$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.